Gene · 55740
Papers2,448
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,448
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neighbourhood sociodemographic factors and COVID-19 vaccine uptake in the Netherlands: an ecological analysis. | BMC Public Health | 2023 | 37660018 | PubTator, text mining | PubMed |
| Limbic Encephalitis as a Late Complication of Relapsing Polychondritis: A Case Report and Review of the Literature. | Mediterr J Rheumatol | 2023 | 37654632 | PubTator, text mining | PubMed |
| Acceptability and readiness to promote human papillomavirus vaccination at ages 9-10 years: a feasibility study among North Carolina clinics. | Pilot Feasibility Stud | 2023 | 37653458 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Thymoma-Associated Myasthenia Gravis With Myocarditis. | Cureus | 2023 | 37637534 | PubTator, text mining | PubMed |
| Altered Proteomic Profile of Exosomes Secreted from Vero Cells Infected with Porcine Epidemic Diarrhea Virus. | Viruses | 2023 | 37631983 | PubTator, text mining | PubMed |
| Nasopharyngeal Meningococcal Carriage among Older Adults in Türkiye (MeninGOLD Study). | Microorganisms | 2023 | 37630655 | PubTator, text mining | PubMed |
| Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus. | Antioxidants (Basel) | 2023 | 37627530 | PubTator, text mining | PubMed |
| Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients. | Biomolecules | 2023 | 37627287 | PubTator, text mining | PubMed |
| The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies. | Cells | 2023 | 37626851 | PubTator, text mining | PubMed |
| Meningococcal burden of disease in Argentina: 10 years epidemiologic review. | Hum Vaccin Immunother | 2023 | 37614151 | PubTator, text mining | PubMed |
| hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC. | J Immunother Cancer | 2023 | 37612043 | PubTator, text mining | PubMed |
| A case report of Erdheim-Chester disease-clinically characterized by recurrent fever, multiple bone destruction, and antinuclear antibodies. | Heliyon | 2023 | 37609395 | PubTator, text mining | PubMed |
| Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. | Cell Mol Life Sci | 2023 | 37598126 | PubTator, text mining | PubMed |
| Epigenome-wide analysis identifies methylome profiles linked to obsessive-compulsive disorder, disease severity, and treatment response. | Mol Psychiatry | 2023 | 37587247 | PubTator, text mining | PubMed |
| Identification and Clinical Correlation Analysis of IFI44 in Systemic Lupus Erythematosus Combined with Bioinformatics and Immune Infiltration Analysis. | J Inflamm Res | 2023 | 37547125 | PubTator, text mining | PubMed |
| HPV disrupt the cytoskeleton in oral squamous cell carcinomas from non-oropharyngeal sites via the E-cadherin/Mena/SMA pathway. | Pathol Res Pract | 2023 | 37544131 | PubTator, text mining | PubMed |
| Neuronal actin cytoskeleton gain of function in the human brain. | EBioMedicine | 2023 | 37517100 | PubTator, text mining | PubMed |
| Unusual presentation of antisynthetase syndrome: a case series and review of the literature. | J Med Case Rep | 2023 | 37516893 | PubTator, text mining | PubMed |
| Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. | Int J Mol Sci | 2023 | 37511303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55740/papers?page=10